About Us

A Swedish specialized CRO

Our expertise is in cellular target engagement. Since 2013, our patented CETSA® (Cellular Thermal Shift Assay) technology, has supported preclinical drug discovery, by providing early insights and confidence to your decisions.​

We offer a range of standardized and customized services, from target discovery to preclinical studies, to provide you with early confidence and insights in your drug discovery project.